+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colchicine Tablets Market - Global Forecast 2026-2032- Product Image
Colchicine Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Colchicine Tablets Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150323
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colchicine Tablets Market is projected to reach USD 568.72 Million in 2026. It is expected to continue growing at a CAGR of 8.34%, reaching USD 915.76 Million by 2032.

Colchicine Tablets: Executive Overview

Colchicine tablets are an established oral therapy used primarily for acute gout flares, gout-flare prevention, and familial Mediterranean fever, subject to country-specific approvals and prescribing guidance. Demand is shaped by the prevalence of hyperuricemia and gout, access to diagnosis, adherence to treatment protocols, safety monitoring, and the availability of alternative formulations and therapies. Because colchicine has a narrow therapeutic margin, product quality, accurate dosing, renal and hepatic risk assessment, and attention to drug interactions remain central to clinical use.

Safety, Access, and Care-Pathway Shifts

The landscape is being reshaped by earlier diagnosis, broader emphasis on long-term urate management, and stronger integration between primary care, rheumatology, pharmacy services, and digital health. Regulatory scrutiny and clinical education increasingly focus on dose adjustment, contraindications, interaction management, and counterfeit prevention. At the same time, generic availability and oral convenience support access, while supply continuity, pharmacovigilance, and patient understanding remain important operational priorities.

Artificial Intelligence and Colchicine Tablet Management

Artificial intelligence can support colchicine-related care by identifying patients at risk of gout flares, flagging potential drug interactions, assisting renal-function-based medication review, and improving adherence monitoring. Health systems may also use machine learning to analyze prescribing patterns, detect unusual safety signals, and prioritize educational outreach. These applications require validated datasets, transparent clinical oversight, privacy safeguards, and careful controls against biased recommendations; AI should complement, rather than replace, clinician judgment and approved prescribing information.

Regional Insights Across the Global Landscape

North America is characterized by comparatively developed clinical infrastructure, established gout-management pathways, and strong attention to medication safety and reimbursement access. Europe combines mature pharmacovigilance systems with country-level differences in reimbursement, prescribing, and regulatory implementation. Asia-Pacific includes diverse healthcare systems, expanding urban demand for chronic-disease care, and uneven access to diagnosis and monitoring. Latin America faces variation in affordability, distribution, and specialist access, while the Middle East is influenced by metabolic-disease burdens, private-sector capacity, and differing regulatory environments. Africa presents substantial opportunities to improve diagnosis, essential-medicine availability, supply reliability, and clinician education.

Group-Level Signals: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets require approaches that account for varied regulatory systems, income levels, and healthcare access, with regional cooperation potentially supporting quality assurance and supply resilience. BRICS countries span large and diverse patient populations and healthcare infrastructures, making local manufacturing capacity, affordability, and consistent clinical guidance important considerations. The European Union benefits from coordinated regulatory principles while retaining national differences in reimbursement and procurement. G7 systems generally emphasize evidence-based prescribing, pharmacovigilance, and integrated chronic-care models. GCC countries often combine advanced urban healthcare facilities with varied procurement structures and expatriate populations. NATO is not a healthcare market bloc, but its members may share preparedness, supply-chain, and health-security interests relevant to continuity of essential medicines.

Country-Level Considerations for Colchicine Tablets

Australia and Canada emphasize regulated access, safety monitoring, and geographically distributed healthcare delivery. Brazil, Mexico, India, China, and Russia combine substantial population needs with regional differences in affordability, procurement, and clinical access. France, Germany, Italy, Spain, and the United Kingdom operate within mature European care systems, with national variation in reimbursement, prescribing pathways, and pharmacy practice. Japan and South Korea have advanced healthcare infrastructures and aging populations, alongside strong expectations for quality, labeling, and medication safety. In the United States, access is influenced by insurance design, pharmacy distribution, prescribing patterns, and heightened attention to interaction and toxicity risks.

Priorities for Industry Leaders and Healthcare Stakeholders

Leaders should prioritize consistent product quality, resilient sourcing, clear labeling, and packaging that reduces dosing errors. Patient-support programs should explain when colchicine is appropriate, how it differs from long-term urate-lowering therapy, and which symptoms require urgent medical attention. Partnerships with clinicians and pharmacists can strengthen renal and hepatic risk review, interaction screening, and adherence support. Organizations should also invest in pharmacovigilance, responsible digital tools, compliant educational content, and region-specific access strategies that reflect local procurement and regulatory requirements.

Research Methodology for the Executive Summary

This summary uses a qualitative, evidence-oriented framework for assessing colchicine tablets across therapeutic use, safety, access, care delivery, technology, and geography. The analysis considers established clinical and regulatory themes, including approved indications, dosing precautions, medication interactions, supply continuity, and healthcare-system variation. Regional, group, and country discussion is comparative rather than quantitative. No market estimates, market shares, forecasts, or company-specific assessments are included; claims should be validated against current national labels, treatment guidelines, regulatory notices, and pharmacovigilance data before operational use.

Conclusion: Building Safe and Reliable Colchicine Access

Colchicine tablets remain relevant to gout and familial Mediterranean fever care, but their value depends on safe prescribing, reliable quality, appropriate patient selection, and sustained clinical education. Regional and country differences in regulation, affordability, diagnosis, and monitoring require tailored execution rather than a single global approach. Industry and healthcare leaders can strengthen outcomes by combining supply resilience, pharmacist and clinician engagement, responsible digital innovation, and rigorous safety surveillance.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Colchicine Tablets Market, by Product Type
7.1. Introduction
7.2. Brand
7.3. Generic
8. Colchicine Tablets Market, by Application
8.1. Introduction
8.2. Cardiovascular Indications
8.3. Familial Mediterranean Fever
8.3.1. Acute Treatment
8.3.2. Prophylaxis
8.4. Gout
8.4.1. Acute Treatment
8.4.2. Prophylaxis
9. Colchicine Tablets Market, by End User
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Private Hospitals
9.2.2. Public Hospitals
9.3. Online Pharmacies
9.3.1. Mail-Order Pharmacies
9.3.2. Web-Based Pharmacies
9.4. Retail Pharmacies
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
10. Colchicine Tablets Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Colchicine Tablets Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Colchicine Tablets Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Accord Healthcare, Inc.
14.2. Amneal Pharmaceuticals, Inc.
14.3. APOTEX Inc.
14.4. Aurobindo Pharma Limited
14.5. Bionpharma Inc.
14.6. Cipla Limited
14.7. Dr. Reddy's Laboratories Ltd.
14.8. Hikma Pharmaceuticals PLC
14.9. Lannett Company, Inc.
14.10. Lupin Limited
14.11. Macleods Pharmaceuticals Ltd.
14.12. Mylan N.V. (now part of Viatris Inc.)
14.13. Rising Pharmaceuticals, Inc.
14.14. Sandoz International GmbH
14.15. Sun Pharmaceutical Industries Ltd.
14.16. Takeda Pharmaceutical Company Limited
14.17. Taro Pharmaceutical Industries Ltd.
14.18. Teva Pharmaceutical Industries Ltd.
14.19. Wockhardt Limited
14.20. Zydus Lifesciences Limited
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Colchicine Tablets Market, Years Considered for the Study
FIGURE 2. Global Colchicine Tablets Market, Research Design
FIGURE 3. Global Colchicine Tablets Market, Research Framework
FIGURE 4. Global Colchicine Tablets Market, Data Triangulation
FIGURE 5. Global Colchicine Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Colchicine Tablets Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Colchicine Tablets Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Colchicine Tablets Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Colchicine Tablets Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Colchicine Tablets Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Colchicine Tablets Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Colchicine Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Colchicine Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Colchicine Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Colchicine Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Colchicine Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Colchicine Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Colchicine Tablets Market Segmentation & Coverage
TABLE 2. Global Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Brand Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Brand Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Brand Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 11. Global Cardiovascular Indications Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Cardiovascular Indications Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Cardiovascular Indications Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Familial Mediterranean Fever Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Familial Mediterranean Fever Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Familial Mediterranean Fever Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Acute Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Acute Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Acute Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gout Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Gout Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Gout Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Acute Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Acute Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Acute Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Mail-Order Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Mail-Order Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Mail-Order Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Web-Based Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Web-Based Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Web-Based Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 70. North America Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. North America Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. North America Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. North America Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 74. North America Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 75. North America Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 77. North America Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 78. North America Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 79. Latin America Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Latin America Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Latin America Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Latin America Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 83. Latin America Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 84. Latin America Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 86. Latin America Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 87. Latin America Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 88. Europe Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Europe Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Europe Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Europe Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 92. Europe Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 93. Europe Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Europe Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 95. Europe Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 96. Europe Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 97. Middle East Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Middle East Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Middle East Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 101. Middle East Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 102. Middle East Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Middle East Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 104. Middle East Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 105. Middle East Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 106. Africa Colchicine Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Africa Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Africa Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Africa Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 110. Africa Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 111. Africa Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Africa Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 113. Africa Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 114. Africa Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 115. Global Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. ASEAN Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. ASEAN Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 120. ASEAN Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 121. ASEAN Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. ASEAN Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 123. ASEAN Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 124. ASEAN Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 125. GCC Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. GCC Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. GCC Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. GCC Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 129. GCC Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 130. GCC Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. GCC Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 132. GCC Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 133. GCC Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 134. European Union Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. European Union Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. European Union Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. European Union Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 138. European Union Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 139. European Union Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. European Union Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 141. European Union Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 142. European Union Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 143. BRICS Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. BRICS Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. BRICS Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. BRICS Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 147. BRICS Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 148. BRICS Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. BRICS Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 150. BRICS Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 151. BRICS Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 152. G7 Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. G7 Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. G7 Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. G7 Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 156. G7 Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 157. G7 Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. G7 Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 159. G7 Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 160. G7 Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 161. NATO Colchicine Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. NATO Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. NATO Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. NATO Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 165. NATO Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 166. NATO Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. NATO Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 168. NATO Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 169. NATO Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 170. Global Colchicine Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 172. United States Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. United States Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. United States Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 175. United States Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 176. United States Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. United States Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 178. United States Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 179. United States Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 180. Canada Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 181. Canada Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Canada Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Canada Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 184. Canada Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 185. Canada Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Canada Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 187. Canada Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 188. Canada Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 189. Mexico Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 190. Mexico Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Mexico Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Mexico Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 193. Mexico Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 194. Mexico Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Mexico Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 196. Mexico Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 197. Mexico Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 198. Brazil Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 199. Brazil Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Brazil Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Brazil Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 202. Brazil Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 203. Brazil Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Brazil Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 205. Brazil Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 206. Brazil Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 207. United Kingdom Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 208. United Kingdom Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. United Kingdom Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United Kingdom Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 211. United Kingdom Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 212. United Kingdom Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. United Kingdom Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 214. United Kingdom Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 215. United Kingdom Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 216. Germany Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 217. Germany Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Germany Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Germany Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 220. Germany Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 221. Germany Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Germany Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 223. Germany Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 224. Germany Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 225. France Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 226. France Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. France Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. France Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 229. France Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 230. France Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. France Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 232. France Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 233. France Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 234. Russia Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 235. Russia Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. Russia Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Russia Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 238. Russia Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 239. Russia Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Russia Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 241. Russia Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 242. Russia Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 243. Italy Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 244. Italy Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Italy Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Italy Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 247. Italy Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 248. Italy Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Italy Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 250. Italy Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 251. Italy Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 252. Spain Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 253. Spain Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Spain Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Spain Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 256. Spain Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 257. Spain Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Spain Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 259. Spain Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 260. Spain Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 261. China Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 262. China Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. China Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. China Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 265. China Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 266. China Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. China Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 268. China Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 269. China Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 270. India Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 271. India Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. India Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. India Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 274. India Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 275. India Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. India Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 277. India Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 278. India Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 279. Japan Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 280. Japan Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Japan Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Japan Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 283. Japan Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 284. Japan Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Japan Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 286. Japan Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 287. Japan Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 288. Australia Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 289. Australia Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. Australia Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. Australia Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 292. Australia Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 293. Australia Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Australia Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 295. Australia Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 296. Australia Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 297. South Korea Colchicine Tablets Market Size, 2017-2032 (USD Million)
TABLE 298. South Korea Colchicine Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. South Korea Colchicine Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. South Korea Colchicine Tablets Market Size, by Familial Mediterranean Fever, 2017-2032 (USD Million)
TABLE 301. South Korea Colchicine Tablets Market Size, by Gout, 2017-2032 (USD Million)
TABLE 302. South Korea Colchicine Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. South Korea Colchicine Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 304. South Korea Colchicine Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 305. South Korea Colchicine Tablets Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 306. Global Colchicine Tablets Market Share, by Key Player, 2025
TABLE 307. Global Colchicine Tablets Market, Key Experts

Companies Mentioned

  • Accord Healthcare, Inc.
  • Amneal Pharmaceuticals, Inc.
  • APOTEX Inc.
  • Aurobindo Pharma Limited
  • Bionpharma Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Hikma Pharmaceuticals PLC
  • Lannett Company, Inc.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Mylan N.V. (now part of Viatris Inc.)
  • Rising Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Taro Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Limited
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Colchicine Market - Global Forecast 2026-2032 - Product Image

Colchicine Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
2026 Colchicine Market Outlook: Size, Share, Growth Trends and Forecast 2025-2034 - Product Image

2026 Colchicine Market Outlook: Size, Share, Growth Trends and Forecast 2025-2034

  • Report
  • 160 Pages
  • Global
From
Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Gout Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Xanthine Oxidase Inhibitors, Uricosurics, Recombinant Uricase, IL-1 Inhibitors, Colchicine, NSAIDs, Corticosteroids, Other Classes), Route Of Administration, Disease Type - Product Image

Gout Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Xanthine Oxidase Inhibitors, Uricosurics, Recombinant Uricase, IL-1 Inhibitors, Colchicine, NSAIDs, Corticosteroids, Other Classes), Route Of Administration, Disease Type

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.